ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Genmab
The Director, Global Market Access & Pricing (Solid Tumor) leads development and execution of global market access and pricing strategies to demonstrate the value of oncology assets to HTA bodies and payers and to ensure optimal patient access. The role provides strategic input across US/EU/Japan regions, partners with cross-functional teams, and supports evidence generation and launch planning. This position is hybrid and based in Princeton, NJ, reporting to senior market access leadership.
Headquarters
Valby, Hovedstaden, Denmark
Company Size
1001-5000 employees
Founded
1999
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genmab.
Genmab didn’t post a salary, so this is our estimate from similar listings.
Genmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Director, Global Value, Access & Pricing – CRC
Revolution Medicines
Market Access MG Lead
argenx
Director of Market Access
WEP Clinical
Market Access Director, Netherlands
Revolution Medicines
Director; Global Value, Access & Pricing; Solid Tumors, Pipeline
BeOne Medicines
Associate Director, Market Access HTA, Spain
Revolution Medicines
